Journal
JOURNAL OF ORTHOPAEDIC TRANSLATION
Volume 9, Issue -, Pages 19-27Publisher
ELSEVIER
DOI: 10.1016/j.jot.2017.03.002
Keywords
cell therapy; homing; mesenchymal stem cells; skeletal diseases
Categories
Funding
- National Natural Science Foundation of China [81371946, 81374568]
- Hong Kong Government Research Grant Council, General Research Fund [470813, 14119115, 9054014]
- China Shenzhen City Science and Technology Bureau [GJHZ20140419120051680, JCYJ20150630165236960]
- SMART program
- ui Che Woo Institute of Innovative Medicine
- Chinese University of Hong Kong
- Lui Che Woo Foundation Limited
Ask authors/readers for more resources
Cell therapy continues to attract growing interest as a promising approach to treat a variety of diseases. Mesenchymal stem cells (MSCs) have been one of the most intensely studied candidates for cell therapy. Since the homing capacity of MSCs is an important determinant of effective MSC-based therapy, the enhancement of homing efficiency is essential for optimizing the therapeutic outcome. Furthermore, trafficking of endogenous MSCs to damaged tissues, also referred to as endogenic stem cell homing, and the subsequent participation of MSCs in tissue regeneration are considered to be a natural self-healing response. Therefore, strategies to stimulate and reinforce the mobilisation and homing of MSCs have become a key point in regenerative medicine. The current review focuses on advances in the mechanisms and factors governing trafficking of MSCs, and the relationship between MSC mobilisation and skeletal diseases, providing insights into strategies for their potential translational implications. (C) 2017 The Authors. Published by Elsevier (Singapore) Pte Ltd on behalf of Chinese Speaking Orthopaedic Society.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available